Filing Details
DarioHealth Corp. (NASDAQ:DRIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:DRIO
DarioHealth Corp. (DRIO) Files Quarterly Report for Q0
DarioHealth Corp. (NASDAQ:DRIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
DarioHealth Corp. (NASDAQ:DRIO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- DarioHealth Corp. (NASDAQ: DRIO) filed its quarterly report (Form 10-Q) with the SEC on August 11, 2026.
- The company's stock trades at $7.67 with a market capitalization of $86.7 million.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance, including emerging trends and updated risk factors.
Market Context
DarioHealth Corp.'s stock currently trades at $7.67 with a market capitalization of $86.7M.
The 10-Q provides DarioHealth Corp.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for DarioHealth Corp. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View DRIO Stock Page
Frequently Asked Questions
Where can I read DRIO's SEC filings?
Browse all filings on our DRIO SEC filings page.
What types of SEC filings does DarioHealth Corp. file?
Public companies like DarioHealth Corp. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.